MétaCan
Menu
Back to cohort
Record W4389053205 · doi:10.1016/j.jhep.2023.10.043

Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

2023· review· en· W4389053205 on OpenAlexaff
Devin Razavi‐Shearer, Hannah Child, K. Razavi-Shearer, Alexis Voeller, Homie Razavi, Marı́a Buti, Frank Tacke, Norah A. Terrault, Stefan Zeuzem, Zaigham Abbas, Alessio Aghemo, Ulus Salih Akarca, Nasser Al Masri, Abdullah A. Alalwan, Marianne Alanko Blomé, Anna Jerkeman, Soo Aleman, Habiba Kamal, Abdullah Alghamdi, Majed Alghamdi, Saad Alghamdi, Waleed Al–Hamoudi, Elsayed Mostafa Ali, Abdulrahman Aljumah, I. Altraif, Tarik Asselah, Oidov Baatarkhuu, Adriana Babameto, Ziv Ben‐Ari, Thomas Berg, Mia J. Biondi, Wornei Silva Miranda Braga, Carlos Eduardo Brandão‐Mello, Robert S. Brown, Maurizia Rossana Brunetto, Joaquín Cabezas, Mariana Cardoso, Alexandra Martins, Henry Lik‐Yuen Chan, Hugo Cheinquer, C.-J. Chen, Hwai‐I Yang, Pei‐Jer Chen, Cheng‐Hung Chien, Wan‐Long Chuang, L. Cisneros Garza, B. Coco, Carla S. Coffin, Nicola Coppola, Markus Cornberg, Antonio Craxı̀, Javier Crespo, Liri Çuko, Victor de Lédinghen, A.‐S. Duberg, Ohad Etzion, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Xavier Forns, Graham R. Foster, James Fung, Giovanni Battista Gaeta, Javier García‐Samaniego, J Genov, Liliana Gheorghe, Patrick Gholam, Robert G. Gish, Jeffrey S. Glenn, Saeed Hamid, Julian Hercun, Yao‐Chun Hsu, Chih-Chien Hu, Jee‐Fu Huang, Ramazan Idılman, Wasim Jafri, Naveed Z. Janjua, Deian Jelev, Jidong Jia, Martin Kåberg, Kelly Kaita, Jia‐Horng Kao, Aamir Khan, Do Young ‍Kim, Loreta A. Kondili, Martin Lagging, Pietro Lampertico, Pablo Lázaro, Jeffrey V. Lazarus, M.-H. Lee, Young‐Suk Lim, Cirley Lobato, Guilherme Macedo, Rui Tato Marinho, Paul Marotta, Maria Cássia Mendes-Corrêa, Nahúm Méndez‐Sánchez, M.-C. Navas, Qing Ning, Necati Örmecı, Mauricio Orrego, Carla Osiowy, Calvin Q. Pan, Mário Guimarães Pessôa, Zahra Zahid Piracha, Corina Silvia Pop, Huma Qureshi, Giovanni Raimondo, Alnoor Ramji, Sofia Ribeiro, Cielo Ríos, Manuel Rodríguez, William Rosenberg, Dominique Roulot, Stephen Ryder, U. Saeed, Rifaat Safadi, Daniel Shouval, Faisal M. Sanai, J.F. Sánchez-Ávila, Teresa Santantonio, Christoph Sarrazin, Wai‐Kay Seto, Marieta Simonova, Junko Tanaka, Tammo Lambert Tergast, Cristina Valente, Juan Miguel Villalobos-Salcedo, Yasir Waheed, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip, J.‐C. Wu, Ming‐Lung Yu, Man‐Fung Yuen, Cihan Yurdaydın, Eli Zuckerman

Bibliographic record

VenueJournal of Hepatology · 2023
Typereview
Languageen
FieldMedicine
TopicHepatitis B Virus Studies
Canadian institutionsPublic Health Agency of CanadaWestern UniversityUniversity of ManitobaCentre Hospitalier de l’Université de MontréalUniversity of CalgaryUniversity of British ColumbiaBC Centre for Disease ControlYork University
FundersGenentechIpsenNovo NordiskEisaiCSL BehringGilead SciencesAlnylam PharmaceuticalsPfizerAllerganEli Lilly and CompanyBristol-Myers Squibb
KeywordsHBsAgHepatitis D virusHepatitis B virusPopulationHepatitis DVirologyHepatitis BDemographyMedicinePrevalenceVirusEnvironmental health

Abstract

fetched live from OpenAlex

BACKGROUND & AIMS: Hepatitis delta virus (HDV) is a satellite RNA virus that requires the hepatitis B virus (HBV) for assembly and propagation. Individuals infected with HDV progress to advanced liver disease faster than HBV-monoinfected individuals. Recent studies have estimated the global prevalence of anti-HDV antibodies among the HBV-infected population to be 5-15%. This study aimed to better understand HDV prevalence at the population level in 25 countries/territories. METHODS: We conducted a literature review to determine the prevalence of anti-HDV and HDV RNA in hepatitis B surface antigen (HBsAg)-positive individuals in 25 countries/territories. Virtual meetings were held with experts from each setting to discuss the findings and collect unpublished data. Data were weighted for patient segments and regional heterogeneity to estimate the prevalence in the HBV-infected population. The findings were then combined with The Polaris Observatory HBV data to estimate the anti-HDV and HDV RNA prevalence in each country/territory at the population level. RESULTS: After adjusting for geographical distribution, disease stage and special populations, the anti-HDV prevalence among the HBsAg+ population changed from the literature estimate in 19 countries. The highest anti-HDV prevalence was 60.1% in Mongolia. Once adjusted for the size of the HBsAg+ population and HDV RNA positivity rate, China had the highest absolute number of HDV RNA+ cases. CONCLUSIONS: We found substantially lower HDV prevalence than previously reported, as prior meta-analyses primarily focused on studies conducted in groups/regions that have a higher probability of HBV infection: tertiary care centers, specific risk groups or geographical regions. There is large uncertainty in HDV prevalence estimates. The implementation of reflex testing would improve estimates, while also allowing earlier linkage to care for HDV RNA+ individuals. The logistical and economic burden of reflex testing on the health system would be limited, as only HBsAg+ cases would be screened. IMPACT AND IMPLICATIONS: There is a great deal of uncertainty surrounding the prevalence of hepatitis delta virus among people living with hepatitis B virus at the population level. In this study, we aimed to better understand the burden in 25 countries and territories, to refine techniques that can be used in future analyses. We found a lower prevalence in the majority of places studied than had been previously reported. These data can help inform policy makers on the need to screen people living with hepatitis B virus to find those coinfected with hepatitis delta virus and at high risk of progression, while also highlighting the pitfalls that other researchers have often fallen into.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.660
Threshold uncertainty score0.752

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0030.000
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.059
GPT teacher head0.367
Teacher spread0.309 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations95
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueJournal of HepatologySame topicHepatitis B Virus StudiesFrench-language works237,207